CellGenes Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $14.5M

  • Investors
  • 3

CellGenes General Information

Description

Manufacturer of stem cell-based therapeutic technologies designed to advance regenerative medicine and address diseases with limited treatment options. The company offers proprietary stem cell engineering platforms, scalable cell expansion and differentiation capabilities, and clinically validated translational pathways, enabling hospitals, clinical research institutions, and pharmaceutical partners to achieve safer cell therapies, broader disease coverage, and effective clinical application.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8th Floor, Building C3
  • Number 11 Kaiyuan Avenue, Huangpu District
  • Guangzhou, Guangdong 517000
  • China
+86 020
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 8th Floor, Building C3
  • Number 11 Kaiyuan Avenue, Huangpu District
  • Guangzhou, Guangdong 517000
  • China
+86 020

CellGenes Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellGenes Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 24-Mar-2026 $14.5M Completed Generating Revenue
5. Later Stage VC (Series B) 01-Jan-2023 Completed Generating Revenue
4. Secondary Transaction - Private 09-Mar-2021 Completed Generating Revenue
3. Early Stage VC (Series A1) 01-Jan-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Jan-2018 $2.28M $2.28M Completed Generating Revenue
1. Secondary Transaction - Private 17-Feb-2017 Completed Generating Revenue
To view CellGenes’s complete valuation and funding history, request access »

CellGenes Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Guangdong Yuecai Zhongyin Private Equity Investment Fund Management PE/Buyout Minority
Green Pine Capital Partners Venture Capital Minority
Daan Incubator Accelerator/Incubator Minority
To view CellGenes’s complete investors history, request access »

CellGenes FAQs

  • When was CellGenes founded?

    CellGenes was founded in 2016.

  • Where is CellGenes headquartered?

    CellGenes is headquartered in Guangzhou, China.

  • What industry is CellGenes in?

    CellGenes’s primary industry is Biotechnology.

  • Is CellGenes a private or public company?

    CellGenes is a Private company.

  • What is CellGenes’s current revenue?

    The current revenue for CellGenes is .

  • How much funding has CellGenes raised over time?

    CellGenes has raised $30.1M.

  • Who are CellGenes’s investors?

    Guangdong Yuecai Zhongyin Private Equity Investment Fund Management, Green Pine Capital Partners, and Daan Incubator have invested in CellGenes.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process